Correlation Between Scpharmaceuticals and CureVac NV
Can any of the company-specific risk be diversified away by investing in both Scpharmaceuticals and CureVac NV at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Scpharmaceuticals and CureVac NV into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Scpharmaceuticals and CureVac NV, you can compare the effects of market volatilities on Scpharmaceuticals and CureVac NV and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Scpharmaceuticals with a short position of CureVac NV. Check out your portfolio center. Please also check ongoing floating volatility patterns of Scpharmaceuticals and CureVac NV.
Diversification Opportunities for Scpharmaceuticals and CureVac NV
0.83 | Correlation Coefficient |
Very poor diversification
The 3 months correlation between Scpharmaceuticals and CureVac is 0.83. Overlapping area represents the amount of risk that can be diversified away by holding Scpharmaceuticals and CureVac NV in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on CureVac NV and Scpharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Scpharmaceuticals are associated (or correlated) with CureVac NV. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of CureVac NV has no effect on the direction of Scpharmaceuticals i.e., Scpharmaceuticals and CureVac NV go up and down completely randomly.
Pair Corralation between Scpharmaceuticals and CureVac NV
Given the investment horizon of 90 days Scpharmaceuticals is expected to under-perform the CureVac NV. In addition to that, Scpharmaceuticals is 1.45 times more volatile than CureVac NV. It trades about -0.25 of its total potential returns per unit of risk. CureVac NV is currently generating about -0.08 per unit of volatility. If you would invest 283.00 in CureVac NV on August 27, 2024 and sell it today you would lose (17.00) from holding CureVac NV or give up 6.01% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Strong |
| Accuracy | 100.0% |
| Values | Daily Returns |
Scpharmaceuticals vs. CureVac NV
Performance |
| Timeline |
| Scpharmaceuticals |
| CureVac NV |
Scpharmaceuticals and CureVac NV Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Scpharmaceuticals and CureVac NV
The main advantage of trading using opposite Scpharmaceuticals and CureVac NV positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Scpharmaceuticals position performs unexpectedly, CureVac NV can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in CureVac NV will offset losses from the drop in CureVac NV's long position.| Scpharmaceuticals vs. Milestone Pharmaceuticals | Scpharmaceuticals vs. Oncolytics Biotech | Scpharmaceuticals vs. Seres Therapeutics | Scpharmaceuticals vs. DiaMedica Therapeutics |
| CureVac NV vs. Eliem Therapeutics | CureVac NV vs. HCW Biologics | CureVac NV vs. Scpharmaceuticals | CureVac NV vs. Milestone Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Rebalancing module to analyze risk-adjusted returns against different time horizons to find asset-allocation targets.
Other Complementary Tools
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume |